课题基金 / 基金详情

The role of mitochondria-associated RING finger proteins in mitochondrial quality

The role of mitochondria-associated RING finger proteins in mitochondrial quality
线粒体相关环指蛋白在线粒体质量中的作用
批准号:
8325565
负责人:
MARIUSZ KARBOWSKI
金额:
$26.46万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2014-08-31

项目摘要

项目成果

MARIUSZ KARBOWSKI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract: Mitochondria are essential for a variety of cellular functions, including ATP production, lipid biosynthesis and calcium homeostasis. Moreover, a number of major cell signaling pathways, including apoptosis, require mitochondria. Consistent with a major role of mitochondria in the control of cell function, mitochondrial defects result in a variety of malignant pathologies. Thus, the molecular components that control mitochondrial homeostasis are likely to be major determinants of cell fate and the well being of the whole organism. However, despite their importance, the mechanisms of mitochondrial quality control, as well as the signaling mechanisms between mitochondria and other cell compartments, are largely unknown. We have identified MARCH5 and IBRDC2, two novel mitochondrial E3 ubiquitin ligases, and have determined that these two proteins are essential for the regulation of mitochondrial function in apoptosis and mitochondrial division, respectively. These results implicate a family of novel mitochondrial membrane-associated RING finger E3 ubiquitin ligases in the regulation of mitochondrial homeostasis through ubiquitin-dependent mechanisms. The present proposal seeks to elucidate the functions of IBRDC2 and MARCH5, and their roles in mitochondrial protein regulation and in membrane dynamics, both in healthy cells and during apoptosis. Biochemical and cellular studies, imaging investigations using time-lapse methods, new fluorescent tools developed by the PI (including photoactivable fluorescent proteins), and a variety of molecular genetic methodologies will be utilized to address the following three questions: 1) What are the biochemical properties of IBRDC2 and MARCH5? The sub-mitochondrial localization, membrane topology and substrate specificity of IBRDC2 and MARCH5 will be determined. 2) How do IBRDC2 and MARCH5 work in the mitochondria of living cells? Studies exploiting gain- and loss-of-function approaches will test the roles of IBRDC2 and MARCH5 in proteasome-dependent mitochondrial protein degradation, as well as in the regulation of membrane dynamics and apoptosis-related mitochondrial protein complexes. These studies will also identify mitochondrial proteins that are under regulatory control of IBRDC2 and MARCH5. 3) What is the influence of IBRDC2 and MARCH5 on specific molecular events in the apoptotic cascade? These studies will determine to what degree IBRDC2 and MARCH5 activities are required for progression of distinct steps of apoptosis. Addressing these questions will improve our general understanding of mitochondrial function and, in the long term, are likely to contribute to the development of novel pharmacological approaches to treat diseases stemming from mitochondrial dysfunction. The proposed studies are part of our long- term effort to understand the normal functions of mitochondria and how mitochondrial defects contribute to disease. Project narrative: We have identified MARCH5 and IBRDC2, two novel mitochondrial E3 ubiquitin ligases, and have determined that these two proteins are essential for the regulation of mitochondrial function in apoptosis and mitochondrial division, respectively. These results implicate a family of novel mitochondrial membrane-associated RING finger E3 ubiquitin ligases in the regulation of mitochondrial homeostasis through ubiquitin-dependent mechanisms. The present proposal seeks to elucidate the functions of IBRDC2 and MARCH5, and their roles in mitochondrial protein regulation and in membrane dynamics, both in healthy cells and during apoptosis. The results of these studies, should improve our general understanding of mitochondrial function and, in the long term, are likely to contribute to the development of novel pharmacological approaches to treat diseases stemming from mitochondrial dysfunction.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/978-1-4419-6706-0_8
发表时间: 2010
期刊: Advances in experimental medicine and biology
影响因子: --
作者: [M. Karbowski]
通讯作者: M. Karbowski
DOI: 10.1016/b978-0-12-801415-8.00004-7
发表时间: 2014
期刊: Methods in enzymology
影响因子: --
作者: [Karbowski M, Cleland MM, Roelofs BA]
通讯作者: Roelofs BA
DOI: 10.1083/jcb.201007013
发表时间: 2010-12-27
期刊: The Journal of cell biology
影响因子: --
作者: [Tanaka A, Cleland MM, Xu S, Narendra DP, Suen DF, Karbowski M, Youle RJ]
通讯作者: Youle RJ
DOI: 10.1091/mbc.e10-09-0748
发表时间: 2011-02-01
期刊: Molecular biology of the cell
影响因子: 3.3
作者: [Xu S, Peng G, Wang Y, Fang S, Karbowski M]
通讯作者: Karbowski M
8
    Ubiquitin-dependent mitochondrial quality control
    • 批准号:
      10369587
    • 项目类别:
    • 资助金额:
      $33.67万
    • 财政年份:
      2019
    • 负责人:
      MARIUSZ KARBOWSKI
    • 依托单位:
    Ubiquitin-dependent mitochondrial quality control
    • 批准号:
      9921417
    • 项目类别:
    • 资助金额:
      $33.67万
    • 财政年份:
      2019
    • 负责人:
      MARIUSZ KARBOWSKI
    • 依托单位:
    Control of mitochondrial proteostasis by AAA-ATPase p97
    • 批准号:
      8342402
    • 项目类别:
    • 资助金额:
      $29.17万
    • 财政年份:
      2012
    • 负责人:
      MARIUSZ KARBOWSKI
    • 依托单位:
    Control of mitochondrial proteostasis by AAA-ATPase p97
    • 批准号:
      8895356
    • 项目类别:
    • 资助金额:
      $29.17万
    • 财政年份:
      2012
    • 负责人:
      MARIUSZ KARBOWSKI
    • 依托单位:
    海外基金